The natural history of chronic widespread pain in patients with axial spondyloarthritis: a cohort study with clinical and self-tracking data (2023)
https://pubmed.ncbi.nlm.nih.gov/36469303/

Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope (2023)
https://pubmed.ncbi.nlm.nih.gov/37197377/

ASAS consensus definition of early axial spondyloarthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/37321799/

Protocol for a systematic literature review of smartphone apps to support the self-management of rheumatic and musculoskeletal diseases: development strategies, theoretical underpinnings and barriers to engagement (2023)
https://pubmed.ncbi.nlm.nih.gov/37516896/

Diagnostic delay in axial spondylarthritis: A lost battle? (2023)
https://pubmed.ncbi.nlm.nih.gov/37658016/

Real-world evidence for secukinumab in UK patients with psoriatic arthritis or radiographic axial spondyloarthritis: interim 2-year analysis from SERENA (2023)
https://pubmed.ncbi.nlm.nih.gov/37663578/

The Future of Axial Spondyloarthritis Rehabilitation: Lessons Learned From COVID‐19 (2022)
https://onlinelibrary.wiley.com/doi/abs/10.1002/acr.24780

Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit (2022)
https://academic.oup.com/rheumatology/article/61/2/734/6274914

The natural history of chronic widespread pain in patients with axial spondyloarthritis: a cohort study with clinical and self-tracking data (2022)
https://academic.oup.com/rheumatology/advance-article-abstract/doi/10.1093/rheumatology/keac679/6873734

Correlates of physical activity in adults with spondyloarthritis and rheumatoid arthritis: a systematic review (2022)
https://pubmed.ncbi.nlm.nih.gov/35672508/

Determinants of Longitudinal Adherence in Smartphone-Based Self-Tracking for Chronic Health Conditions: Evidence from Axial Spondyloarthritis (2021)
https://researchportal.bath.ac.uk/en/publications/determinants-of-longitudinal-adherence-in-smartphone-based-self-t

A novel IMU-based clinical assessment protocol for Axial Spondyloarthritis: a protocol validation study (2021)
https://peerj.com/articles/10623/

Understanding flare in axial spondyloarthritis: novel insights from daily self-reported flare experience (2021)
https://pubmed.ncbi.nlm.nih.gov/34926981/

Practical Approaches to Bone Marrow Fat Fraction Quantification Across Magnetic Resonance Imaging Platforms (2020)
https://doi.org/10.1002/jmri.27039

BRITSpA at five (2020)
https://academic.oup.com/rheumatology/article/59/4/699/5618659

Real-world experience of secukinumab treatment for ankylosing spondylitis at the Royal National Hospital for Rheumatic Diseases, Bath (2020)
https://link.springer.com/article/10.1007/s10067-020-04944-5

Evaluating patient-reported fatigue and serum biomarkers in axial spondyloarthritis (2020)
https://academic.oup.com/rheumatology/advance-article-abstract/doi/10.1093/rheumatology/keaa115/5817416?redirectedFrom=fulltext

The Future of Axial Spondyloathritis Treatment (2020)
https://www.rheumatic.theclinics.com/article/S0889-857X(20)30014-4/abstract

Response to lower dose TNF inhibitors in axial spondylarthritis; a “real world” multicentre observational study (2020)
https://academic.oup.com/rheumap/article/4/2/rkaa015/5836837

Back pain, ankylosing spondylitis and social media usage; a descriptive analysis of current activity (2020)
https://link.springer.com/article/10.1007%2Fs00296-020-04600-w

Physical therapy in axial spondyloarthritis: guidelines, evidence and clinical practice (2020)
https://journals.lww.com/co-rheumatology/Abstract/2020/07000/Physical_therapy_in_axial_spondyloarthritis_.7.aspx

Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5 (2020)
https://journals.lww.com/cmj/Fulltext/2020/11050/Secukinumab_provided_significant_and_sustained.1.aspx

Evaluation of a patient self-stratification methodology to identify those in need of shielding during COVID-19 (2020)
https://www.rcpjournals.org/content/clinmedicine/early/2020/09/10/clinmed.2020-0469

Axial spondyloarthritis 10 years on: still looking for the lost tribe (2020)
https://academic.oup.com/rheumatology/article/59/Supplement_4/iv25/5923444

Longitudinal profiling of the gut microbiome in patients with psoriatic arthritis and ankylosing spondylitis: a multicentre, prospective, observational study (2020)
https://bmcrheumatol.biomedcentral.com/articles/10.1186/s41927-020-00155-2

Risk mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey (2020)
https://onlinelibrary.wiley.com/doi/abs/10.1111/bjd.19755

Increased Risk of Hypertension Associated with Spondyloarthritis Disease Duration: Results from the ASAS-COMOSPA Study (2019)
https://www.jrheum.org/content/46/7/701

Association of Diverticulitis with Prolonged Spondyloarthritis: An Analysis of the ASAS-COMOSPA International Cohort (2019)
https://www.mdpi.com/2077-0383/8/3/281

Exploring the Future Role of Self-Tracking Data in the Rheumatology Clinic (2019)
https://pubmed.ncbi.nlm.nih.gov/30923269/

AxSpA patients who also meet criteria for fibromyalgia : identifying distinct patient clusters using data from a UK national register (BSRBR-AS) (2019)
https://doi.org/10.1186/s41927-019-0066-7

Exploring sub-optimal response to tumour necrosis factor inhibitors in axial spondyloarthritis (2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649897/pdf/rkz012.pdf

Recommendations for acquisition and interpretation of MRI of the spine and sacroiliac joints in the diagnosis of axial spondyloarthritis in the UK (2019)
https://academic.oup.com/rheumatology/article/58/10/1831/5484832

Use of Complementary and Alternative Medicine in Axial Spondyloarthritis: A Qualitative Exploration of Self-Management (2019)
https://www.mdpi.com/2077-0383/8/5/699

Living with Ankylosing Spondylitis: An open response survey exploring physical activity experiences. (2019)
https://academic.oup.com/rheumap/article/3/2/rkz016/5523856

(Un)Spoken realities of living with axial spondyloarthritis: a qualitative study focused on couple experiences (2019)
https://bmjopen.bmj.com/content/9/7/e025261.long

Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy (2019)
https://pubmed.ncbi.nlm.nih.gov/30788779/

Awareness of axial spondyloarthritis among chiropractors and osteopaths: findings from a UK Web-based survey (2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785804/pdf/rkz034.pdf

A truly complementary approach: A qualitative exploration of complementary and alternative medicine practitioners’ views of treating ankylosing spondylitis (2018)
https://onlinelibrary.wiley.com/doi/abs/10.1002/msc.1217

The clinical utility of human leucocyte antigen B27 in axial spondyloarthritis (2018)
https://academic.oup.com/rheumatology/article/57/6/959/4211017

Short-term Repeat Magnetic Resonance Imaging Scans in Suspected Early Axial Spondyloarthritis Are Clinically Relevant Only in HLA-B27-positive Male Subjects (2018)
https://www.jrheum.org/content/45/2/202

Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort (2018)
https://academic.oup.com/rheumatology/article/57/4/619/4767791

Sleep in ankylosing spondylitis and non-radiographic axial spondyloarthritis: associations with disease activity, gender and mood (2018)
https://link.springer.com/article/10.1007%2Fs10067-018-3984-7

Biologics for treating axial spondyloarthritis (2018)
https://www.tandfonline.com/doi/full/10.1080/14712598.2018.1468884

Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register (2018)
https://academic.oup.com/rheumatology/article/57/11/1982/5056975

Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis — findings from a United Kingdom cohort: Reply (2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649945/pdf/rky037.pdf

Monitoring patients with ankylosing spondylitis on anti-TNF monotherapy: too much too often? (2017)
https://www.tandfonline.com/doi/full/10.1080/03009742.2016.1209554

Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis (2017)
https://ard.bmj.com/content/76/4/701

Should axial spondyloarthritis without radiographic changes be treated with anti-TNF agents? (2017)
https://link.springer.com/article/10.1007%2Fs00296-016-3635-8

Fatigue contributes to work productivity impairment in patients with axialspondyloarthritis: a cross-sectional UK study (2017)
https://www.clinexprheumatol.org/abstract.asp?a=11115

Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: A prospective cross-sectional comparative study (2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609020/pdf/13075_2017_Article_1417.pdf

Advancing research paradigms and pathophysiological pathways in psoriatic arthritis and ankylosing spondylitis: Proceedings of the 2017 Platform for the Exchange of Expertise and Research (PEER) Meeting (2017)
https://www.sciencedirect.com/science/article/pii/S0049017218304177?via%3Dihub

Prevalence and factors associated with disturbed sleep in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review. (2016)
https://link.springer.com/article/10.1007%2Fs00296-016-3589-x

BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics (2016)
https://academic.oup.com/rheumatology/article/56/2/313/2631549

Clinical outcomes and progression to orthopaedic surgery in juvenile versus adult-onset ankylosing spondylitis (2015)
https://onlinelibrary.wiley.com/doi/full/10.1002/acr.22500

Serum Soluble Bone Turnover Biomarkers in Psoriatic Arthritis and Psoriatic Spondyloarthropathy (2015)
https://www.jrheum.org/content/42/1/21

Delay to diagnosis in axial spondyloarthritis: are we improving in the UK? (2015)
https://academic.oup.com/rheumatology/article/54/12/2283/1793449

Comment on: delay to diagnosis in axial spondyloarthritis: are we improving in the UK?: (2015)
https://academic.oup.com/rheumatology/article/55/9/1707/1744590

Reliability, feasibility and sensitivity of four peripheral radiographic scores for PsA. (2014)
https://onlinelibrary.wiley.com/doi/full/10.1002/acr.22104

Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis. (2013)
https://academic.oup.com/rheumatology/article/52/2/261/1831519

Expanding the spectrum of inflammatory spinal disease: AS it was, as it is now. (2013)
https://academic.oup.com/rheumatology/article/52/12/2103/1801115

Juvenile Versus Adult-onset Ankylosing Spondylitis — Clinical, Radiographic, and Social Outcomes. A Systematic Review (2013)
https://www.jrheum.org/content/40/11/1797

Challenges in the management and research of juvenile onset ankylosing spondylitis (2013)
https://www.openaccessjournals.com/articles/challenges-in-the-management-and-research-of-juvenileonset-ankylosing-spondylitis.pdf

Assessment of impact of flares in ankylosing spondylitis disease activity using the flare illustration (2008)
https://academic.oup.com/rheumatology/article/47/8/1213/1786832

The assessment of ankylosing spondylitis in clinical practice. (2007)
https://www.nature.com/articles/ncprheum0591